E. R. Chulie Ulloa
We investigate novel therapeutic strategies (e.g., immune-based therapies and drug-repurposing) to treat drug-tolerant or -resistant bacterial pathogens.
Melissa Lodoen
My research program is focused on the innate immunity, neuroinflammation, and host-pathogen interactions during infection with Toxoplasma gondii.
Don Forthal
My laboratory focuses on understanding how antibodies interact with cells bearing Fc receptors (such as macrophages, monocytes, NK cells) and
Philip L. Felgner
The UCI Vaccine R&D Center is supported by the NIH to develop vaccine and vaccine adjuvants for infectious diseases. There
Elizabeth N. Bess
Uncovering chemical reactions encoded in the gut microbiome to understand and treat human disease
Rosa M. Andrade
Understanding the Redox homeostasis of Toxoplasma gondii to find new therapeutic targets
Katherine Xue
The Xue lab studies how microbes interact and evolve in complex communities like the human gut microbiome using a combination